Open access
Oct 2026
Real-world effectiveness and safety of Ocrelizumab in a gulf multiple sclerosis cohort: extension of the Q-OCRE study to 451 patients.
Ocrelizumab showed robust effectiveness and a favorable safety profile in this Gulf cohort, with disability trajectories dissociating by phenotype, with disability trajectories dissociating by phenotype.
Khaled Zammar, Majd A. Abualrob, Randa Yasin et al.
· Multiple Sclerosis and Relat... · 0 citations